ORIGENIS
Origenis provides small molecule drug discovery services. It offers drug design, chemical synthesis, and biological characterization services combined with its proprietary small molecule drug discovery technology platform. Its technology platforms include MOREsystem and MolMind which provide direct exploitation of huge chemical spaces and delivers straightforward synthetic routes generating patentable drug candidates in less time.
ORIGENIS
Industry:
Biotechnology Pharmaceutical
Founded:
2005-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.origenis.de
Total Employee:
11+
Status:
Active
Contact:
+498978016760
Email Addresses:
[email protected]
Technology used in webpage:
Euro OVH Envoy 3 To 9 CcTLD Redirects
Similar Organizations
FNP Clinical
FNP Clinical is a contract Research Organisation offering comprehensive set of services for Phase I-IV clinical trials in Russia.
Optimed SA
Optimed SA is a contract research organization, provides services in clinical research.
Total Scientific
Total Scientific is a contract research organisation that specialises in providing biomarker-related services to the pharmaceutical
Viroclinics Biosciences
Viroclinics Biosciences is a contract research and clinical laboratory service company providing diagnostic and preclinical studies.
Zelmic
Zelmic is a contract research organization dedicated to local delivery of small molecules, peptides and proteins
Official Site Inspections
http://www.origenis.de Semrush global rank: 5.25 M Semrush visits lastest month: 1.56 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Origenis"
Team | Origenis | Planegg
Prior Origenis, as Head of Molecular Modeling at Morphochem, he invented protein- and ligand-based drug design methods, QSPR, parallel evolutionary search algorithms, and …See details»
Origenis - Crunchbase Company Profile & Funding
Origenis is a contract research organisation offering services in drug design, synthesis, and characterisation.See details»
Origenis GmbH - Innovations- und Gründerzentrum …
Origenis was founded in October 2005 through a management buy-out by Michael Almstetter, Dr. Michael Thormann, and Dr. Andreas Treml, who decided to continue the development and …See details»
Origenis GmbH (DE) - Life-Sciences-Europe.com
Nov 1, 2005 Origenis (Group) Predecessor: Morphochem (Group) Industry: drug discovery services: Person: Almstetter, Michael (Origenis 202012 Managing Director) Person 2: …See details»
Top 19 German Biotechnology Firms to Watch - Inven
15. Origenis GmbH. Website: origenis.de; Headquarters: Planegg, Bavaria, Germany; Founded: 2005; Headcount: 11-50; LinkedIn; Origenis is a company based in Germany that specializes in drug discovery and development. They …See details»
Careers | Origenis | Planegg
Origenis hires people with a passion to make a difference to the health of millions of people globally. top of page. Our Work. Our Vision; What we do; How we work; Where we come from; R&D. ... (AT)origenis.de. March 2021: Yes, we hire …See details»
Origenis | VentureRadar
Website: http://www.origenis.de/ Develops novel small molecule drugs targeting difficult-to-reach tissues for diseases like Parkinson's, Alzheimer's, cancer, and eye ...See details»
Michael Thormann - Managing Director - Origenis GmbH | LinkedIn
Co-Founder and Managing Director of Origenis GmbH · Origenis GmbH · Universitat de Barcelona · Greater Munich Metropolitan Area · 500+ connections on LinkedIn. View Michael …See details»
Origenis - Company profile | ensun
Origenis was founded in October 2005 through a management buy-out of former Morphochem AG’s technology platform. We focus on small molecule drugs that we design to select targets …See details»
Origenis - Contacts, Employees, Board Members, Advisors & Alumni
Origenis is a contract research organisation offering services in drug design, synthesis, and characterisation. New. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
Drug Pipeline | Origenis | Planegg
Our drug pipeline consists of preclinical small molecule drugs that are designed to hit select targets with high potency and outstanding selectivity in difficult-to-reach tissues of interest like …See details»
Dr. Jean Tassel - Senior Research Scientist - Origenis GmbH - XING
Origenis GmbH. 3 Jahre und 5 Monate, Sep. 2007 - Jan. 2011. PhD Thesis. TUM München. 1 Jahr, Aug. 2005 - Juli 2006. Research trainee. Boehringer Ingelheim. ... CPE Lyon (École …See details»
Organisation vs. Organization: What’s the Difference?
The US nuclear base at Incirlik is a key part of western defences; were Turkey to leave the organisation its loss would be a serious blow. –The Telegraph Gianforte said the $50,000 …See details»
Prof. Raphael: A Heresia de Orígenes - Blogger
Dec 4, 2017 Apesar de simpatizar com muitos ensinamentos gnósticos, Orígenes procurou contradizer estas ideias em particular, considerando-as um perigo para a autêntica tradição …See details»
Origenis founds biotech company Neuron23 in Silicon Valley …
Martinsried near Munich, Germany, March 01, 2021 – Origenis GmbH, a privately held German biopharmaceutical company, announces the formation and financing of Neuron23 Inc. in South …See details»
Origenis founds biotech Neuron23 in Silicon Valley together with …
Origenis successfully establishes its new business model for the clinical development of its neuroprotective drug pipeline Martinsried near Munich, Germany, March 01, 2021 - Origenis …See details»
AI Innovation Platform | Origenis | Planegg
Our AI-driven drug design and synthesis planning engine combines soft-synthesis planning fed by >150,000 reaction rules applied to existing in-house and commercial building blocks, state-of …See details»
De principiis (Origenes) – Wikipedia
Der Anfang von Origenes’ De principiis in einem karolingischen Manuskript des 10. Jahrhunderts: Liber primus Periarcon Origenis emendatum (Herzog August Bibliothek Cod. Guelf. 57 Weiss., …See details»
Tractatus Origenis de libris SS. scripturar - Archive.org
Jun 13, 2021 Tractatus Origenis de libris SS. scripturar by Origenes (185-254); Batiffol, Pierre (1861-1929) Publication date 1900 Usage Public Domain Mark 1.0 Topics Origenes - Opera, …See details»
Aureus Pharma licenses AurWEB to Origenis
September 6, 2006 Paris, FRANCE, September 2006 – Aureus Pharma a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, …See details»